Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2005
12/29/2005US20050288314 2,4-diaminoquinazolines for spinal muscular atrophy
12/29/2005US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005DE102004029308A1 Substituierte Benzoylpyrazole als Herbiszide Substituted benzoylpyrazoles as Herbiszide
12/29/2005DE102004028862A1 3-Aminoindazole 3 aminoindazoles
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2570264A1 3-aminoindazoles
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1609471A1 Remedy and/or preventive for lung diseases
12/28/2005EP1608643A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists
12/28/2005EP1608642A1 Enantioselective hydrogenation of intermediates during tipranavir synthesis
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608634A2 Methods for isolating crystalline form i of 5-azacytidine
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608630A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
12/28/2005EP1608629A1 Benzyl-pyridazinons as reverse transcriptase inhibitors
12/28/2005EP1608626A1 Migrastatin analog compositions and uses thereof
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1497240A4 Non-heating clay composites for building materials
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1373241B1 Method for producing optically active dihydropyrones
12/28/2005EP1355650B1 Combination of active ingredients containing alfuzosine and apomorphine
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/28/2005EP0805683B1 5-fluoro-2',3'-unsaturated-pyrimidine nucleosides
12/28/2005CN1714089A Novel use of substituted aminomethyl chromans
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714081A Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1713909A Aminoindazole derivatives and use thereof as kinase inhibitors
12/27/2005US6979736 Process for the preparation of benazepril hydrochloride
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2156287C Indolin-2-one derivative
12/22/2005WO2005121132A1 Fused heterocyclic compound having anti-hcv effect
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121129A1 Novel propenone derivatives containing aromatic rings, a maufacturing process thereof and a composition containing the same using as an antiinflammatory agent
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121097A2 Pyrazole derivatives, compositions containing such compounds and methods of use
12/22/2005WO2005121093A1 Lxr receptor modulators
12/22/2005WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005WO2005120505A2 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/22/2005WO2005120503A2 N-aryl piperidine compounds for inhibiting hiv infection
12/22/2005WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005082863A3 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
12/22/2005WO2005072082A3 2-guanidinylimidazolidinedione compounds and methods of making and using thereof
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005WO2005060663A3 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
12/22/2005US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282864 Indole derivatives as H3 inverse agonists
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282856 3-Cyano-quinoline derivatives
12/22/2005US20050282845 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors
12/22/2005US20050282825 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
12/22/2005US20050282824 Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems
12/22/2005US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/22/2005US20050282816 Pyrazinylmethyl lactam derivatives
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282808 activated blood coagulation factor X inhibitor; 5-Dimethylaminocarbonyl-3-[4-(N-formyl-N-methylamino)cyclohexylcarbonylamino]-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide; for treatment of thrombosis; free of phospholipidosis and/or hepatotoxicity; oral administration; bioavailability
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282801 Novel phenantridine analogues and uses thereof
12/22/2005US20050282709 Substituted benzoylpyrazoles as herbicides
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2564642A1 Lxr receptor modulators
12/22/2005CA2564499A1 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1606287A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606274A1 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 694